Latest Asset Valuation News

Aspermont Limited reported a 6% rise in revenue and a 12% increase in EBITDA for the year ended September 2025, yet posted a net loss of A$2.576 million. The company’s financial health shows mixed signals amid ongoing operational improvements.

CD Private Equity Fund II reported a reduced net loss of $2.43 million for the half-year to September 2025, supported by $9.45 million in distributions from portfolio realisations. Despite foreign exchange headwinds, the Fund maintains a diversified portfolio and a positive long-term return track record.

CD Private Equity Fund I reported a $2.6 million net loss for the half-year ended 30 September 2025, driven by foreign exchange impacts and fair value adjustments, while distributing 8 cents per unit amid ongoing portfolio realisations.

Ryman Healthcare reported a 13% revenue increase to NZD 413.8 million for H1 2025, yet swung to a significant net loss of NZD 45.2 million and suspended dividends, raising questions about its financial trajectory.

Marimaca Copper Corp. reports a robust working capital position supported by recent capital raises, while managing a complex receivable linked to a liquidation process. The company remains well-positioned to fund operations over the next year but faces uncertainties beyond that horizon.

Infratil Limited reported a 7% rise in operational EBITDAF to NZ$514 million for the first half of FY26, driven by strong performances from Longroad Energy and CDC Data Centres. The company also announced significant divestments, including its 20% stake in Fortysouth and a legacy property asset, while maintaining its interim dividend.

CVC Limited marked a milestone year with strategic land acquisitions and planning successes, boosting its land portfolio value despite modest net profits. The company’s focus on industrial, residential, and data centre developments positions it for future growth.

CVC Limited has announced a $50 million offer of unsecured, redeemable notes to strengthen its balance sheet and capitalize on strategic real estate opportunities across Australia. The notes feature a floating interest rate and a reinvestment option for existing noteholders.

4DMedical has responded to ASX queries over its FY2025 financial report, clarifying assumptions behind intangible asset valuations and addressing the auditor’s qualified opinion.

Locate Technologies reported steady Q1 FY26 revenue with a strategic pivot to the NZX to better support its Bitcoin treasury ambitions. The company’s Locate2u unit showed promising growth, while Zoom2u faced challenges amid softer consumer spending.

Finexia Financial Group has revised its FY25 financial results, increasing impairment losses on its Stayco investment and raising its total loss before tax to $6.82 million.

ECP Emerging Growth Limited has reported a stable financial position for its convertible notes in Q3 2025, with a loan-to-value ratio of just 21.54% and no changes to the conversion price.